Stock Details
BDX is Becton, Dickinson and Company's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 251.55$. Average daily volumn in 3 months 933.12k. Market cap 64.85B



Stock symbol : BDX. Exchange : NYSE. Currency : USD
Lastest price : 227.39$. Total volume : 583.73k. Market state REGULAR
Click reload if you want to check the lastest price on market!!!

Becton, Dickinson and Company (BDX)
Last Price
227.39$
Change
-2.98
Volume
583.73k

Previous Close230.37
Open229.63
Day Range224.69-229.95
Bid227.31 x 800
Ask227.53 x 1k
Volume583.73k
Average Volume933.12k
Market Cap64.85B
Beta0.59
52 Week Range224.69-277.29
Trailing P/E34.56
Foward P/E18.61
Dividend (Yield %)1.49%
Ex-Dividend Date2022-09-08



Financial Details


According to Becton, Dickinson and Company's financial reports the company's revenue in 2021 were 20.25B an increase( +17.65%) over the years 2020 revenue that were of 17.12B. In 2021 the company's total earnings were 2.09B while total earnings in 2020 were 874M( +128.83%).


Loading ...



Organization

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and ... extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Market Cap:
64.85B
Revenue:
20.25B
Total Assets:
53.87B
Total Cash:
2.28B


News about "Becton, Dickinson and Company"

becton-dickinson-and-companys-nysebdx-intrinsic-value-is-potentially-64-above-its-share-price-image

Becton, Dickinson and Company's (NYSE:BDX) Intrinsic Value Is Potentially 64% Above Its Share Price

Source from : Nasdaq - 9 hours ago

Does the September share price for Becton, Dickinson and Company (NYSE:BDX) reflect what it's really worth? Today, we will estimate the stock's intrinsic value by projecting its future cash flows and ...See details»


becton-dickinson-and-company-nysebdx-shares-sold-by-money-concepts-capital-corp-image

Becton, Dickinson and Company (NYSE:BDX) Shares Sold by Money Concepts Capital Corp

Source from : Defense World - 14 hours ago

Money Concepts Capital Corp reduced its position in Becton, Dickinson and Company (NYSE:BDX – Get Rating) by 19.2% during the 2nd quarter, according to its most recent filing with the Securities and ...See details»


veriti-management-llc-has-482000-stock-position-in-becton-dickinson-and-company-nysebdx-image

Veriti Management LLC Has $482,000 Stock Position in Becton, Dickinson and Company (NYSE:BDX)

Source from : Defense World - 12 hours ago

Veriti Management LLC lifted its position in shares of Becton, Dickinson and Company (NYSE:BDX – Get Rating) by 13.9% in the second quarter, according to its most recent disclosure with the SEC. The ...See details»


Four Days Left To Buy Becton, Dickinson and Company (NYSE:BDX) Before The Ex-Dividend Date

Source from : Yahoo Finance - 26 days ago

Readers hoping to buy Becton, Dickinson and Company (NYSE:BDX) for its dividend will need to make their move shortly, as the stock is about to trade ex-dividend. The ex-dividend date is one ...See details»


BDX Becton, Dickinson and Company

Source from : Seeking Alpha - 6 days ago

**NM signifies a non meaningful value. A dash signifies the data is not available.See details»


Becton Dickinson Stuck with Hefty Fine in Needle Case

Source from : MD&M East - 22 days ago

A federal judge has ordered Becton Dickinson & Co. to pay $340 million to Retractable Technologies, Inc. (RVP) in a long-running dispute over the smaller company's allegations of false advertising. In ...See details»


Becton Dickinson taps Johnston County for new manufacturing plant

Source from : The Business Journals - 23 days ago

A global medical technology company is expanding its footprint in Johnston County with plans for a new manufacturing operation. Becton, Dickinson and Company (NYSE: BDX) will invest between $25 ...See details»


are-becton-dickinson-and-companys-nysebdx-fundamentals-good-enough-to-warrant-buying-given-the-stocks-recent-weakness-image

Are Becton, Dickinson and Company's (NYSE:BDX) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Source from : Yahoo Finance - 1 days ago

Becton Dickinson (NYSE:BDX) has had a rough month with its share price down 10%. However, the company's fundamentals look pretty decent, and long-term financials are usually aligned with future market ...See details»


With 90% institutional ownership, Becton, Dickinson and Company (NYSE:BDX) is a favorite amongst the big guns

Source from : Yahoo Finance - 28 days ago

To get a sense of who is truly in control of Becton, Dickinson and Company (NYSE:BDX), it is important to understand the ownership structure of the business. With 90% stake, institutions possess the ...See details»


Becton, Dickinson And Q4 2010 Earnings Call Transcript

Source from : TheStreet.com - 17 days ago

Then I'll spend some time highlighting the company's strategy and key focus areas for 2011 and beyond. Next, David will provide a drill down financial view of our company overall and segment ...See details»


Global Surgical Sealants Market Report 2022-2028: Featuring Key Players 3M, Becton, Dickinson, and Co, Medtronic & Others

Source from : Yahoo - 13 days ago

The "Global Surgical Sealants Market Research and Forecast 2022-2028" report has been added to ResearchAndMarkets.com's offering. The global surgical sealants market is anticipated to grow at a CAGR ...See details»


Becton Dickinson's (NYSE:BDX) earnings growth rate lags the 5.5% CAGR delivered to shareholders

Source from : Yahoo Style Australia - 5 days ago

If you buy and hold a stock for many years, you'd hope to be making a profit. Furthermore, you'd generally like to ...See details»


Bioprocess Technology Market to record USD 55.84 Bn growth -- Evolving Opportunities with Advanced Instruments LLC and Becton Dickinson and Co.

Source from : Yahoo Finance - 22 days ago

Technavio identifies the following as the key players in the market: Advanced Instruments LLC Becton Dickinson and Co. Boehringer Ingelheim International GmbH Catalent Inc. Motley Fool ...See details»


Diabetes Care Devices Market Still Has Room to Grow | Emerging Players Becton, Dickinson, Dexcom

Source from : Digital Journal - 16 days ago

The Major Players Covered in this Report: Abbott, F. Hoffmann-La Roche Ltd, Novo Nordisk A/S, Becton, Dickinson & Company (Embecta Corp.), Terumo Corporation, B. Braun Melsungen AG, Medtronic ...See details»